Principal Financial Group Inc. increased its holdings in AdaptHealth Corp. (NASDAQ:AHCO – Get Rating) by 41.1% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 665,908 shares of the company’s stock after buying an additional 194,055 shares during the period. Principal Financial Group Inc.’s holdings in AdaptHealth were worth $12,799,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Versant Capital Management Inc purchased a new stake in AdaptHealth during the third quarter valued at about $26,000. Group One Trading L.P. raised its position in AdaptHealth by 134.3% during the first quarter. Group One Trading L.P. now owns 3,720 shares of the company’s stock valued at $60,000 after purchasing an additional 2,132 shares in the last quarter. Tower Research Capital LLC TRC raised its position in AdaptHealth by 49.0% during the third quarter. Tower Research Capital LLC TRC now owns 4,957 shares of the company’s stock valued at $93,000 after purchasing an additional 1,630 shares in the last quarter. Point72 Hong Kong Ltd purchased a new stake in AdaptHealth during the first quarter valued at about $82,000. Finally, KBC Group NV purchased a new stake in AdaptHealth during the third quarter valued at about $120,000. Hedge funds and other institutional investors own 86.33% of the company’s stock.
AdaptHealth Stock Down 3.4 %
NASDAQ AHCO opened at $10.57 on Friday. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.23 and a quick ratio of 0.97. The stock has a market capitalization of $1.42 billion, a PE ratio of 88.08, a PEG ratio of 0.84 and a beta of 0.66. AdaptHealth Corp. has a 1 year low of $10.00 and a 1 year high of $27.48. The business’s 50-day moving average is $12.01 and its 200 day moving average is $17.32.
Analysts Set New Price Targets
A number of equities research analysts have weighed in on the company. TheStreet downgraded AdaptHealth from a “c-” rating to a “d+” rating in a research report on Thursday, April 6th. Bank of America downgraded AdaptHealth from a “buy” rating to a “neutral” rating and lowered their price target for the company from $21.00 to $12.00 in a research report on Tuesday, May 9th. Deutsche Bank Aktiengesellschaft downgraded AdaptHealth from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $28.00 to $11.30 in a report on Wednesday, May 10th. Robert W. Baird decreased their price objective on AdaptHealth from $23.00 to $20.00 in a report on Wednesday, May 10th. Finally, Royal Bank of Canada decreased their price objective on AdaptHealth from $24.00 to $18.00 in a report on Thursday, May 11th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $18.92.
AdaptHealth Company Profile
AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs.
- Get a free copy of the StockNews.com research report on AdaptHealth (AHCO)
- Ralph Lauren’s Styled Dividend Is Still In Season
- Dollar Tree Falls As Theft Cuts Into Bottom Line
- Best Buy’s Comeback Is Still At Play, Earnings Call For Patience
- e.l.f. Beauty Has Giant Quarter, Shares Hit New High
- If You Can Only Pick One Stock For The Rest Of 2023, Pick Nvidia
Want to see what other hedge funds are holding AHCO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AdaptHealth Corp. (NASDAQ:AHCO – Get Rating).
Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.